580 related articles for article (PubMed ID: 16848908)
21. Epigenetic inactivation of TMS1/ASC in ovarian cancer.
Terasawa K; Sagae S; Toyota M; Tsukada K; Ogi K; Satoh A; Mita H; Imai K; Tokino T; Kudo R
Clin Cancer Res; 2004 Mar; 10(6):2000-6. PubMed ID: 15041718
[TBL] [Abstract][Full Text] [Related]
22. Aberrant methylation and deacetylation of deleted in liver cancer-1 gene in prostate cancer: potential clinical applications.
Guan M; Zhou X; Soulitzis N; Spandidos DA; Popescu NC
Clin Cancer Res; 2006 Mar; 12(5):1412-9. PubMed ID: 16533763
[TBL] [Abstract][Full Text] [Related]
23. [The methylation and mRNA expression of SLC5A8 and TMS1/ASC genes in human glioma].
Jiang Z; Li XG; Hu J; Lu DR; Zhou W; Jiang YQ; Li CY
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(5):292-7. PubMed ID: 17456354
[TBL] [Abstract][Full Text] [Related]
24. Epigenetic inactivation of TSLC1 gene in nasopharyngeal carcinoma.
Hui AB; Lo KW; Kwong J; Lam EC; Chan SY; Chow LS; Chan AS; Teo PM; Huang DP
Mol Carcinog; 2003 Dec; 38(4):170-8. PubMed ID: 14639656
[TBL] [Abstract][Full Text] [Related]
25. Identification of HRK as a target of epigenetic inactivation in colorectal and gastric cancer.
Obata T; Toyota M; Satoh A; Sasaki Y; Ogi K; Akino K; Suzuki H; Murai M; Kikuchi T; Mita H; Itoh F; Issa JP; Tokino T; Imai K
Clin Cancer Res; 2003 Dec; 9(17):6410-8. PubMed ID: 14695142
[TBL] [Abstract][Full Text] [Related]
26. Epigenetic regulation of the KAI1 metastasis suppressor gene in human prostate cancer cell lines.
Sekita N; Suzuki H; Ichikawa T; Kito H; Akakura K; Igarashi T; Nakayama T; Watanabe M; Shiraishi T; Toyota M; Yoshie O; Ito H
Jpn J Cancer Res; 2001 Sep; 92(9):947-51. PubMed ID: 11572762
[TBL] [Abstract][Full Text] [Related]
27. Gene silencing of MIR22 in acute lymphoblastic leukaemia involves histone modifications independent of promoter DNA methylation.
Li X; Liu J; Zhou R; Huang S; Huang S; Chen XM
Br J Haematol; 2010 Jan; 148(1):69-79. PubMed ID: 19807731
[TBL] [Abstract][Full Text] [Related]
28. ASC/TMS1, a caspase-1 activating adaptor, is downregulated by aberrant methylation in human melanoma.
Guan X; Sagara J; Yokoyama T; Koganehira Y; Oguchi M; Saida T; Taniguchi S
Int J Cancer; 2003 Nov; 107(2):202-8. PubMed ID: 12949795
[TBL] [Abstract][Full Text] [Related]
29. Epigenetic inactivation of the dioxin-responsive cytochrome P4501A1 gene in human prostate cancer.
Okino ST; Pookot D; Li LC; Zhao H; Urakami S; Shiina H; Igawa M; Dahiya R
Cancer Res; 2006 Aug; 66(15):7420-8. PubMed ID: 16885337
[TBL] [Abstract][Full Text] [Related]
30. Deletional, mutational, and methylation analyses of CDKN2 (p16/MTS1) in primary and metastatic prostate cancer.
Jarrard DF; Bova GS; Ewing CM; Pin SS; Nguyen SH; Baylin SB; Cairns P; Sidransky D; Herman JG; Isaacs WB
Genes Chromosomes Cancer; 1997 Jun; 19(2):90-6. PubMed ID: 9171999
[TBL] [Abstract][Full Text] [Related]
31. Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells.
Lee SH; Kim J; Kim WH; Lee YM
Oncogene; 2009 Jan; 28(2):184-94. PubMed ID: 18850007
[TBL] [Abstract][Full Text] [Related]
32. Unique methylation pattern of oncostatin m receptor gene in cancers of colorectum and other digestive organs.
Deng G; Kakar S; Okudiara K; Choi E; Sleisenger MH; Kim YS
Clin Cancer Res; 2009 Mar; 15(5):1519-26. PubMed ID: 19223499
[TBL] [Abstract][Full Text] [Related]
33. Methylation-induced silencing of ASC/TMS1, a pro-apoptotic gene, is a late-stage event in colorectal cancer.
Riojas MA; Guo M; Glöckner SC; Machida EO; Baylin SB; Ahuja N
Cancer Biol Ther; 2007 Nov; 6(11):1710-6. PubMed ID: 17986858
[TBL] [Abstract][Full Text] [Related]
34. High-frequency promoter hypermethylation of the deleted in liver cancer-1 gene in multiple myeloma.
Song YF; Xu R; Zhang XH; Chen BB; Chen Q; Chen YM; Xie Y
J Clin Pathol; 2006 Sep; 59(9):947-51. PubMed ID: 16489177
[TBL] [Abstract][Full Text] [Related]
35. CpG methylation at promoter site -140 inactivates TGFbeta2 receptor gene in prostate cancer.
Zhao H; Shiina H; Greene KL; Li LC; Tanaka Y; Kishi H; Igawa M; Kane CJ; Carroll P; Dahiya R
Cancer; 2005 Jul; 104(1):44-52. PubMed ID: 15895377
[TBL] [Abstract][Full Text] [Related]
36. Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), a gene encoding an inhibitor of matrix metalloproteinases in human glioma cells.
Konduri SD; Srivenugopal KS; Yanamandra N; Dinh DH; Olivero WC; Gujrati M; Foster DC; Kisiel W; Ali-Osman F; Kondraganti S; Lakka SS; Rao JS
Oncogene; 2003 Jul; 22(29):4509-16. PubMed ID: 12881707
[TBL] [Abstract][Full Text] [Related]
37. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer.
Cameron EE; Bachman KE; Myöhänen S; Herman JG; Baylin SB
Nat Genet; 1999 Jan; 21(1):103-7. PubMed ID: 9916800
[TBL] [Abstract][Full Text] [Related]
38. Promoter CpG island hypermethylation- and H3K9me3 and H3K27me3-mediated epigenetic silencing targets the deleted in colon cancer (DCC) gene in colorectal carcinogenesis without affecting neighboring genes on chromosomal region 18q21.
Derks S; Bosch LJ; Niessen HE; Moerkerk PT; van den Bosch SM; Carvalho B; Mongera S; Voncken JW; Meijer GA; de Bruïne AP; Herman JG; van Engeland M
Carcinogenesis; 2009 Jun; 30(6):1041-8. PubMed ID: 19329758
[TBL] [Abstract][Full Text] [Related]
39. The essential role of histone H3 Lys9 di-methylation and MeCP2 binding in MGMT silencing with poor DNA methylation of the promoter CpG island.
Zhao W; Soejima H; Higashimoto K; Nakagawachi T; Urano T; Kudo S; Matsukura S; Matsuo S; Joh K; Mukai T
J Biochem; 2005 Mar; 137(3):431-40. PubMed ID: 15809347
[TBL] [Abstract][Full Text] [Related]
40. Incubation with somatostatin, 5-aza decitabine and trichostatin up-regulates somatostatin receptor expression in prostate cancer cells.
Liu Z; Marquez M; Nilsson S; Holmberg AR
Oncol Rep; 2008 Jul; 20(1):151-4. PubMed ID: 18575731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
